Online citations, reference lists, and bibliographies.
← Back to Search

Multifunctional Albumin-MnO₂ Nanoparticles Modulate Solid Tumor Microenvironment By Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor And Enhance Radiation Response.

P. Prasad, C. Gordijo, A. Z. Abbasi, A. Maeda, Angela Ip, A. M. Rauth, R. Dacosta, X. Wu
Published 2014 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Insufficient oxygenation (hypoxia), acidic pH (acidosis), and elevated levels of reactive oxygen species (ROS), such as H2O2, are characteristic abnormalities of the tumor microenvironment (TME). These abnormalities promote tumor aggressiveness, metastasis, and resistance to therapies. To date, there is no treatment available for comprehensive modulation of the TME. Approaches so far have been limited to regulating hypoxia, acidosis, or ROS individually, without accounting for their interdependent effects on tumor progression and response to treatments. Hence we have engineered multifunctional and colloidally stable bioinorganic nanoparticles composed of polyelectrolyte-albumin complex and MnO2 nanoparticles (A-MnO2 NPs) and utilized the reactivity of MnO2 toward peroxides for regulation of the TME with simultaneous oxygen generation and pH increase. In vitro studies showed that these NPs can generate oxygen by reacting with H2O2 produced by cancer cells under hypoxic conditions. A-MnO2 NPs simultaneously increased tumor oxygenation by 45% while increasing tumor pH from pH 6.7 to pH 7.2 by reacting with endogenous H2O2 produced within the tumor in a murine breast tumor model. Intratumoral treatment with NPs also led to the downregulation of two major regulators in tumor progression and aggressiveness, that is, hypoxia-inducible factor-1 alpha and vascular endothelial growth factor in the tumor. Combination treatment of the tumors with NPs and ionizing radiation significantly inhibited breast tumor growth, increased DNA double strand breaks and cancer cell death as compared to radiation therapy alone. These results suggest great potential of A-MnO2 NPs for modulation of the TME and enhancement of radiation response in the treatment of cancer.
This paper references
10.1109/memb.2004.1360409
pH imaging
R.J. Gillies (2004)
10.3389/fonc.2013.00113
DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy
E. Mladenov (2013)
10.1038/nrc2255
A microenvironmental model of carcinogenesis
R. Gatenby (2008)
Soon-Shiong, P. SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
N Desai (2009)
10.1211/0022357021778268
Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery
E. Goldberg (2002)
10.1111/j.1549-8719.2010.00029.x
Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre‐Clinical Models
D. Fukumura (2010)
10.1186/1471-2407-11-167
Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
S. Rademakers (2010)
10.1016/J.BIOS.2003.11.019
A novel glucose ENFET based on the special reactivity of MnO2 nanoparticles.
X. Luo (2004)
10.1016/J.MATLET.2006.07.165
Preparation of MnO2 nanoparticles by directly mixing potassium permanganate and polyelectrolyte aqueous solutions
Yonglan Luo (2007)
10.1016/S0014-5793(00)02197-9
Hydrogen peroxide in the human body
B. Halliwell (2000)
pH imaging. A review of pH measurement methods and applications in cancers.
R. Gillies (2004)
Toxicological considerations of clinically applicable nanoparticles
L. Yildirimer (2011)
10.1021/nl902697j
Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules.
Pilar Rivera-Gil (2009)
Serganova, I. Real Time Imaging of HIF-1R Stabilization and Degradation
E. Moroz (2009)
10.1007/S00018-007-7390-6
Hypoxia and breast cancer: prognostic and therapeutic implications.
K. Lundgren (2007)
10.1038/sj.bjc.6601766
Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines
T. Kalliomäki (2004)
10.1016/J.NANTOD.2011.10.001
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
10.1021/acsnano.5b00886
Cosolvent approach for solution-processable electronic thin films.
Zhaoyang Lin (2015)
10.1080/10731190903043218
Hemoglobin-based Oxygen Carriers Combined with Anticancer Drugs May Enhance Sensitivity of Radiotherapy and Chemotherapy to Solid Tumors
W. Wu (2009)
10.1038/35025220
Angiogenesis in cancer and other diseases
P. Carmeliet (2000)
10.1016/j.mehy.2009.04.002
A novel combination chemotherapy integrating with intratumoral chemotherapy.
Lichun Yang (2009)
10.1016/J.CANLET.2006.10.029
Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy.
M. López-Lázaro (2007)
10.1007/s10555-007-9066-y
Hypoxia: A key regulator of angiogenesis in cancer
D. Liao (2007)
Nab Technology: A Drug Delivery Platform Utilizing Endothelial Gp60 Receptor-Based Transport and Tumour-Derived SPARC for Targeting. Drug Delivery Rep
N Desai (2007)
10.1002/smll.201001144
Synthesis and characterization of ratiometric ion-sensitive polyelectrolyte capsules.
L. L. Del Mercato (2011)
10.1016/j.molonc.2008.03.006
Molecular aspects of tumour hypoxia
S. Rademakers (2008)
10.1371/journal.pone.0005077
Real-Time Imaging of HIF-1α Stabilization and Degradation
E. Moroz (2009)
10.1038/nbt1220
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging
H. Zhang (2006)
10.1016/J.ELECOM.2007.08.013
Choline biosensors based on a bi-electrocatalytic property of MnO2 nanoparticles modified electrodes to H2O2
Yu-Hui Bai (2007)
10.1002/ADFM.200901581
Glucose‐Responsive Bioinorganic Nanohybrid Membrane for Self‐Regulated Insulin Release
C. Gordijo (2010)
10.1002/cphc.200900849
Ion and pH sensing with colloidal nanoparticles: influence of surface charge on sensing and colloidal properties.
F. Zhang (2010)
10.1038/nrc2540
The impact of O2 availability on human cancer
Jessica A. Bertout (2008)
Anti-Angiogenic Therapeutic Drugs for Treatment of Human Cancer
H. Wu (2008)
10.1117/1.3533264
Multispectral fluorescence imaging to assess pH in biological specimens.
Matthew R. Hight (2011)
10.1371/journal.pone.0005396
A Commensal Helicobacter sp. of the Rodent Intestinal Flora Activates TLR2 and NOD1 Responses in Epithelial Cells
Nadia Chaouche-Drider (2009)
10.1002/smll.200801546
Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects.
A. AlKilany (2009)
Principles of Cancer Management: Radiation Therapy
S. Hellman (1997)
Why Do Cancers
R. A. Gatenby (2004)
10.1128/MCB.16.9.4604
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
J. Forsythe (1996)
10.1002/ANIE.200300568
Tailor-made polyelectrolyte microcapsules: from multilayers to smart containers.
Claire Peyratout (2004)
Ion andpH Sensingwith Colloidal Nanoparticles: Influence of Surface Charge on Sensing and Colloidal Properties. Chemphyschem
F. Zhang (2010)
10.1158/1078-0432.CCR-05-1634
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
N. Desai (2006)
10.1016/j.tips.2012.01.005
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
G. Semenza (2012)
10.1593/TLO.09109
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients.
N. Desai (2009)
Nab Technology : A Drug Delivery Platform Utilising Endothelial gp 60 Receptor-based Transport and Tumour-derived SPARC for Targeting I
N. Desai (2009)
10.1038/nrc1478
Why do cancers have high aerobic glycolysis?
R. Gatenby (2004)
10.1111/j.1582-4934.2009.00994.x
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
J. Chiche (2010)
10.1016/j.ejpb.2012.09.001
pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
A. Shalviri (2012)
10.1039/c2an35700c
BSA-templated MnO2 nanoparticles as both peroxidase and oxidase mimics.
X. Liu (2012)
10.1016/J.NANO.2007.10.021
Nanoparticle albumin bound (nab) technology: targeting tumors through the endothelial gp60 receptor and SPARC
N. Desai (2007)
Staining Patterns and Colocalization of Pimonidazole, HIF-1R, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
(2011)
Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements.
P. Vaupel (1991)
Winegarden, N. A.; et al. In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation
A Maeda
10.1371/journal.pone.0040381
Developmental Changes in the Metabolic Network of Snapdragon Flowers
J. Muhlemann (2012)
10.1016/S1053-4296(96)80032-4
Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers.
Overgaard (1996)
10.2174/156652409788167087
Hypoxia and radiation therapy: past history, ongoing research, and future promise.
S. Rockwell (2009)
10.1021/BM990006K
pH-induced coacervation in complexes of bovine serum albumin and cationic polyelectrolytes.
K. Kaibara (2000)
10.1371/journal.pone.0042133
In Vivo Optical Imaging of Tumor and Microvascular Response to Ionizing Radiation
A. Maeda (2012)



This paper is referenced by
10.1016/j.jcis.2020.09.028
Dendritic organosilica nanospheres with large mesopores as multi-guests vehicle for photoacoustic/ultrasound imaging-guided photodynamic therapy.
Yuting Huang (2020)
10.1039/c9sc02107h
Strategies based on metal-based nanoparticles for hypoxic-tumor radiotherapy
Chenyang Zhang (2019)
10.1158/0008-5472.CAN-15-3475
Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia.
A. Z. Abbasi (2016)
10.1016/j.biomaterials.2018.08.014
Hypoxia-responsive block copolymer radiosensitizers as anticancer drug nanocarriers for enhanced chemoradiotherapy of bulky solid tumors.
W. Yin (2018)
10.7150/ntno.22754
Oxygen Self-Sufficient Amphiphilic Polypeptide Nanoparticles Encapsulating BODIPY for Potential Near Infrared Imaging-guided Photodynamic Therapy at Low Energy
L. Liu (2018)
10.1002/jcp.25859
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
Rana Jahanban-Esfahlan (2018)
10.1002/adhm.201700646
Construction of Silica‐Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine
Y. Zhou (2017)
10.1007/s12274-018-2092-y
Scavenging of reactive oxygen and nitrogen species with nanomaterials
Carolina A. Ferreira (2018)
10.1016/j.biomaterials.2017.06.007
Targeting epithelial-mesenchymal transition: Metal organic network nano-complexes for preventing tumor metastasis.
Jin-xuan Fan (2017)
10.1021/acsami.5b10241
Altered Cell Cycle Arrest by Multifunctional Drug-Loaded Enzymatically-Triggered Nanoparticles.
C. Huang (2016)
10.1093/nsr/nwaa160
Advances in nanomaterials for treatment of hypoxic tumor
Mei-Zhen Zou (2020)
10.1088/0957-4484/27/2/025101
Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
Yongwei Hao (2016)
10.3390/ph11040133
Functional Polymer Nanocarriers for Photodynamic Therapy
T. Li (2018)
10.3762/bjnano.11.15
Rational design of block copolymer self-assemblies in photodynamic therapy
M. Demazeau (2020)
10.1021/acsami.7b16000
Multifunctional Bi2WO6 Nanoparticles for CT-Guided Photothermal and Oxygen-free Photodynamic Therapy.
C. Zhang (2018)
10.1016/j.biomaterials.2017.08.030
Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer.
Fengqiao Li (2017)
10.7150/thno.17381
Radionuclide I-131 Labeled Albumin-Paclitaxel Nanoparticles for Synergistic Combined Chemo-radioisotope Therapy of Cancer
Longlong Tian (2017)
10.1002/smll.201700640
Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy.
Longlong Tian (2017)
10.1016/j.ajps.2019.06.001
Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
Xiaohan Zhou (2020)
10.1002/adma.201806381
Breaking the Depth Dependence by Nanotechnology-Enhanced X-Ray-Excited Deep Cancer Theranostics.
W. Fan (2019)
10.3390/md16120510
Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis
Sung-Won Shin (2018)
10.1021/acsami.6b13493
PB@Au Core-Satellite Multifunctional Nanotheranostics for Magnetic Resonance and Computed Tomography Imaging in Vivo and Synergetic Photothermal and Radiosensitive Therapy.
Yan Dou (2017)
10.1002/ADFM.201600676
Modulation of Hypoxia in Solid Tumor Microenvironment with MnO2 Nanoparticles to Enhance Photodynamic Therapy
W. Zhu (2016)
10.1007/s11095-016-1947-8
Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma
Mihaela Aldea (2016)
10.1016/j.canlet.2020.05.032
Hypoxia-responsive nanoparticles for tumor-targeted drug delivery.
Y. Li (2020)
10.1002/SMTD.202000566
Construction of Smart Manganese Dioxide‐Based All‐in‐One Nanoplatform for Cancer Diagnosis and Therapy
Xiangmei Liu (2020)
10.1002/anie.201706910
Manganese Dioxide Nanozymes as Responsive Cytoprotective Shells for Individual Living Cell Encapsulation.
W. Li (2017)
10.7150/thno.37586
A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy
Y. Liu (2019)
10.1038/s42003-020-1070-6
A Cu9S5 nanoparticle-based CpG delivery system for synergistic photothermal-, photodynamic- and immunotherapy
Lulu Zhou (2020)
10.1038/s41467-019-09158-1
Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy
W. Fan (2019)
10.1007/s12274-016-1274-8
Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy
Xuejiao Song (2016)
10.1002/smll.201701621
Dual-Stage Light Amplified Photodynamic Therapy against Hypoxic Tumor Based on an O2 Self-Sufficient Nanoplatform.
Li-Han Liu (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar